A new preprint study shatters the idea that pediatric long COVID is just a mild or different version of the adult form.
It shows that children share the same core immune patterns - and, strikingly, some resemble those seen in chronic infections like HIV.🧵
The paper message is clear - pediatric LC is biologically defined immune dysfunction.
Children display
shifts in monocytes (↑ non-classical, ↓ CCR6),
T cell changes (↑ Tregs, ↓ central memory CD4, exhausted CD8),
exhausted B cells.
At the root lies a failure of antigen-presenting cells (monocytes & dendritic cells).
Normally, they carry viral information to T and B cells. But in LC, they express less CCR6/CCR7 - they can’t migrate properly to lymph nodes or activate adaptive immunity.
“Suppressed expression of CCR6 and CCR7… could impair antigen presentation and adaptive immunity.”
The consequence?
B cells don’t mount a strong antibody response.
Children with LC had significantly lower anti-RBD IgG and IgA titers, and their antibodies neutralized the virus less effectively.
The virus can persist in tissues, like the gut.
Meanwhile, T and NK cells become hyperactivated.
On the surface this looks like a strong immune defense. But in reality, it’s a dead end.
These cells show exhaustion markers (PD1, CD57, CD38, HLA-DR↑).
“Elevated expression of activation and exhaustion markers…”
A vicious cycle?
Persistence - activation - exhaustion - persistence again.
And here’s the striking part - the authors explicitly point to parallels with HIV.
“Elevated CXCR3 expression on CD8 TCM has also been reported in people living with HIV-1, suggesting a shared trait of chronic viral infections.”
The same is true for B cells.
Cluster 15 B cells show an exhausted-like phenotype -
“…commonly observed in chronic viral infections such as HIV-1.”
SARS-CoV-2 can imprint the immune system in children in ways that mimic chronic viral disease.
In pediatric LC, CD8 stem-cell like memory T cells (TSCM) decreased, while central memory T cells (TCM) increased.
And within TCM, there was a shift toward CXCR3+/CCR6+ cells - a phenotype of chronic stimulation.
The clinical point is sobering.
Weak antibodies + exhausted T/NK cells = a recipe for viral persistence.
When APCs don’t work (CCR6/CCR7↓), B cells never make high-quality antibodies.
The virus hides, the immune system pushes harder, and burns itself out.
The result?
A state of chronic immune imbalance.
Maybe less dramatic than HIV, but uncannily similar.
Pediatric LC emerges as a model of chronic viral immunopathology - not a psychological aftermath, but a biological condition with measurable immune signatures.
And perhaps we won’t need to argue about these parallels for long.
The authors themselves are already drawing them - between pediatric LC, adults with LC, and chronic infections like HIV.
Pujol et al., 2025. Pediatric Long COVID Is Characterized by Myeloid CCR6 Suppression and Immune Dysregulation. biorxiv.org/content/10.110…
Dobře si to přečtěte @szupraha @ZdravkoOnline @msmtcr @Hygiena_cz. LC je dnes nejčastější chronické onemocnění u dětí - překonává astma.
Tohle jsou následky vaší nečinnosti.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
A new preprint study followed the same individuals before and after SARS-CoV-2 infection and asked a simple question -
What happens to immune memory after COVID?
Not during acute illness.
Not only in long COVID.
But months later, in people considered recovered.
The researchers focused on memory T cells - the cells that allow us to respond quickly when we encounter familiar pathogens again.
They tested responses to common, everyday threats
Influenza A
Varicella-zoster virus (VZV)
Staphylococcus aureus
Prenatal COVID can shift the trajectory of brain development.
The differences are measurable - and they appear before diagnoses exist.
It’s based on neonatal brain MRI and standardized developmental testing🧵
What study is this?
A prospective study (Brain, Behavior, and Immunity, 2025)
children exposed to SARS-CoV-2 in utero
brain MRI ~2 weeks after birth
developmental testing at 2 years (Bayley-III, ITSEA)
compared to a pre-pandemic control cohort
The study asks whether the exposed group as a whole shows a shifted developmental pattern.
This is about a population-level shift, not a few extreme cases.
The authors show that COVID-19 can disrupt the heart’s electrical wiring (the cardiac conduction system) -causing bradycardia, pauses, and AV block...🧵
... even when they can’t detect viral proteins in the heart, pointing instead to innate immune signaling (IFN/JAK–STAT) plus mitochondrial oxidative stress (ROS) as the likely drivers.
What they did.
Syrian golden hamsters infected intranasally with SARS-CoV-2 (Delta), followed for 4 weeks.
Continuous telemetry in freely moving animals. ECG + breathing + body temperature.
Interferon-stimulated genes, cytokines, macrophages in the conduction system, and gap-junction proteins.
A new study (Cell Reports, 2026) raises an uncomfortable question.
Is metformin really immunologically neutral when used outside diabetes?
Metformin is widely discussed beyond diabetes - aging, cancer, infections, even immune modulation.🧵
In mouse models, long-term metformin exposure caused thymic shrinkage - the thymus is where T cells are made and educated.
The thymus is where T cells are educated.
During development, double-positive (CD4+CD8+) thymocytes undergo positive selection - cells that can recognize self-MHC survive, others die.
It’s not just how much protein, but how proteins are chemically modified (oxidation, glycation, etc), shifting them toward pro-coagulant behavior and impaired microcirculation - and different phenotypes (Long COVID vs POTS) show different PTM signatures.
This chemistry is endogenous. These are modifications of our own proteins, not foreign substances.
Post-COVID brain fog is everywhere - but mechanisms are still debated. This poster asks a clean question - do people with post-COVID brain fog show blood signals consistent with BBB (blood–brain barrier) permeability and immune dysregulation?🧵
Study design. Cross-sectional (one timepoint). 279 participants without prior dementia/cognitive impairment. 51 COV- and 228 COV+. Within COV+, 96 had post-COVID brain fog. 35 had newly diagnosed MCI (= mild cognitive impairment) post-COVID.
What they measured (fasting plasma)
cytokines
BBB disruption/permeability markers (Simoa SP-X)
phosphorylated tau (Simoa HD-X)
Plus concurrent cognitive testing and consensus diagnosis (NACC/UDS3).